15-min delayed · Aug 27, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 1 firms covering Curis Inc, 1 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. Targets are tightly clustered, $43.00 to $43.00, so the covering firms are broadly aligned. The average target of $43.00 sits 2748% above the current $1.51. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $-1.63 next quarter toward $-6.01 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS1 ratings
Strong Buy
Strong Buy00%
Buy1100%
Hold00%
Sell00%
Strong Sell00%
Based on 1 analysts giving stock ratings to Curis Inc.
As of Aug, 1 of 1 firms rate CRIS a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
CRIS EPS & revenue forecast
EPS · NEXT QUARTER
$-1.63
Range $-1.75 – $-1.50 · 2 analysts · -84% YoY
Next period, 2 analysts expect Curis Inc to earn $-1.63 a share (range $-1.75 – $-1.50), versus $-9.95 a year earlier. Full-year consensus is $-23.78, growing to $-6.01 the year after.
REVENUE · NEXT QUARTER
$0
Range $0 – $0 · 2 analysts · -100% YoY
Revenue is expected to reach $0 (range $0 – $0), -100.0% year-over-year. Full-year consensus is $0, rising to $9.3M next year.
Top analysts covering Curis Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on CRIS.
#1
EW
Edward White
HC Wainwright & Co. · Rank #283
Buy
$16.00+959.6% to target
Overall win rate
31%
+ Follow
#2
Joseph Pantginis
HC Wainwright & Co. · Rank #298
Buy
$17.00+1025.8% to target
Overall win rate
33%
+ Follow
#3
SN
Sara Nik
HC Wainwright & Co.
Buy
$43.00+2747.7% to target
Coverage
—
+ Follow
#4
SD
Srikripa Devarakonda
Truist Securities
Buy
No targeton CRIS
Coverage
—
+ Follow
CRIS stock forecast FAQ
What is CRIS's average 12-month price target?+
The 1 analysts with a live target average $43.00 for Curis Inc over the next 12 months, ranging from a $43.00 high to a $43.00 low.
Is CRIS stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 1 analyst ratings, 1 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
How many Wall Street analysts cover CRIS?+
1 analysts have an active rating on Curis Inc, and 1 firms carry a live 12-month price target.
Who is the most accurate analyst covering CRIS?+
Among analysts who currently cover CRIS, Edward White of HC Wainwright & Co. has the strongest overall Quantellect track record (Rank #283). Their current call is Buy with a $16.00 target.
What is Curis Inc's projected EPS for next quarter?+
The consensus estimate is $-1.63 per share (range $-1.75 – $-1.50) across 2 analysts. Full-year EPS is projected at $-23.78, rising to $-6.01 the following year.
How much revenue is Curis Inc expected to report next quarter?+
Consensus revenue is $0 (range $0 – $0). Full-year revenue is projected at $0, growing to $9.3M next year.
Have analysts been upgrading or downgrading CRIS lately?+
As of Aug, 1 of 1 firms rate CRIS a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their CRIS calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
